Immunology
-
An autoantigen profile from Jurkat T-Lymphoblasts provides a molecular guide for investigating autoimmune sequelae of COVID-19
This article has 5 authors:Reviewed by ScreenIT
-
Predicted impact of the viral mutational landscape on the cytotoxic response against SARS-CoV-2
This article has 5 authors:Reviewed by ScreenIT
-
Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection
This article has 17 authors:Reviewed by ScreenIT
-
SARS-CoV-2 Lambda Variant Remains Susceptible to Neutralization by mRNA Vaccine-elicited Antibodies and Convalescent Serum
This article has 6 authors:Reviewed by ScreenIT
-
Ad26.COV2.S elicited neutralizing activity against Delta and other SARS-CoV-2 variants of concern
This article has 21 authors:Reviewed by ScreenIT
-
Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples
This article has 15 authors:Reviewed by ScreenIT
-
Comparative Computational Modeling of the Bat and Human Immune Response to Viral Infection with the Comparative Biology Immune Agent Based Model
This article has 2 authors:Reviewed by ScreenIT
-
Varenicline Prevents SARS-CoV-2 Infection In Vitro and in Rhesus Macaques
This article has 6 authors:Reviewed by ScreenIT
-
The SARS-CoV-2 host cell membrane fusion protein TMPRSS2 is a tumor suppressor and its downregulation correlates with increased antitumor immunity and immunotherapy response in lung adenocarcinoma
This article has 4 authors:Reviewed by ScreenIT
-
OXSR1 inhibits inflammasome activation by limiting potassium efflux during mycobacterial infection
This article has 10 authors:Reviewed by Review Commons